1044598-91-5

基本信息
4-[4-[[2-(4-氯苯基)-5,5-二甲基-1-環(huán)己烯]甲基]-1-哌嗪基]苯甲酸
4-[4-[[2-(4-氯苯基)-5,5-二甲基環(huán)己-1-烯基]甲基]哌嗪-1-基]苯甲酸
4-[4-[[2-(4-Chlorophenyl)-5,5-diMethyl-1-cyclohexenyl]Methyl]-1-
3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoic acid
4-(4-((2-(4-Chlorophenyl)-5,5-diMethylcyclohex-1-enyl)Methyl)piperazin-1-yl)benzoic acid
4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexenyl]methyl]-1-piperazinyl]benzoic acid
4-(4-{[2-(4-chlorophenyl)-5,5-diMethylcyclohex-1-en-1-yl]Methyl}piperazin-1-yl)benzoic acid
4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]benzoic Acid
Benzoic acid, 4-[4-[[2-(4-chlorophenyl)-5,5-diMethyl-1-cyclohexen-1-yl]Methyl]-1-piperazinyl]-
4-(4-((4'-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)be
4-(4-((4'-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)benzo
物理化學性質
制備方法
![4-[4-[[2-(4-氯苯基)-5,5-二甲基環(huán)己-1-烯基]甲基]哌嗪-1-基]苯甲酸乙酯](/CAS2/GIF/1065604-70-7.gif)
1065604-70-7
![4-[4-[[2-(4-氯苯基)-5,5-二甲基-1-環(huán)己烯]甲基]-1-哌嗪基]苯甲酸](/CAS2/GIF/1044598-91-5.gif)
1044598-91-5
步驟E:合成3.7:將NaOH(19.70 g,492.48 mmol)溶于H2O(300.00 mL)和MeOH(100.00 mL)的混合溶劑中,隨后加入3.6(57.50 g,123.12 mmol)的THF(600.00 mL)溶液。反應混合物在室溫下攪拌,并在80°C下加熱1小時。反應完成后,減壓濃縮除去過量溶劑,將殘余物倒入冰水(1 L)中。用酸調節(jié)混合物的pH至5-6,此時有白色固體析出。通過過濾收集固體,干燥后得到3.7(50.00 g,113.90 mmol,收率93%)。產物經質譜(ESI)分析顯示m/z = 439 [M + H]+。1H NMR(400 MHz, DMSO-d6)數據如下:δ 10.63(br, 1H), 7.75(d, 2H, J = 8.8 Hz), 7.38(d, 2H, J = 8.4 Hz), 7.12(d, 2H, J = 8.0 Hz, Ph), 6.91(m, 2H, J = 8.8 Hz), 3.84(m, 2H), 3.58(m, 2H), 3.39(m, 2H), 2.78(m, 2H), 2.28(m, 2H), 2.21(m, 2H), 1.47(m, 2H), 1.00(s, 6H)。
參考文獻:
[1] Patent: WO2017/101851, 2017, A1. Location in patent: Paragraph 0140; 0147
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 21, p. 6902 - 6915
[3] Patent: US2009/318689, 2009, A1. Location in patent: Page/Page column 32-33
[4] Patent: WO2017/123616, 2017, A1. Location in patent: Paragraph 00150